Medartis Investor Relations Material
Latest events
H2 2024
Medartis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Medartis Holding AG
Access all reports
Medartis Holding AG is a Swiss medical technology company specializing in the development, manufacture, and distribution of surgical implants and instruments for the treatment of bone fractures and deformities. The company’s products focus on areas such as craniofacial, upper extremity, and lower extremity applications, serving orthopedic and reconstructive surgery needs. The company is headquartered in Basel, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Medartis Holding AG
H2 2024
Medartis Holding AG
H1 2024
Medartis Holding AG
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
MED
Country
🇨🇭 Switzerland